CRS Products

12 Congressional Research Service reports and publications

FDA’s Role in the Medical Product Supply Chain and Considerations During COVID-19
2020-09-01 · Reports · R46507 · HTML available · PDF available
The U.S. Blood Supply and the COVID-19 Response: In Brief
2020-08-26 · Reports · R46375 · HTML available · PDF available
Development and Regulation of Medical Countermeasures for COVID-19 (Vaccines, Diagnostics, and Treatments): Frequently Asked Questions
2020-06-25 · Reports · R46427 · HTML available · PDF available
Selected Health Provisions in Title III of the CARES Act (P.L. 116-136)
2020-04-29 · Reports · R46334 · HTML available · PDF available
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116123): First Coronavirus Supplemental
2020-03-25 · Reports · R46285 · HTML available · PDF available
FDA Regulation of Cannabidiol (CBD) Consumer Products
2020-02-10 · Resources · IF11250 · HTML available · PDF available
FDA Regulation of Cannabidiol (CBD) Consumer Products: Overview and Considerations for Congress
2020-01-21 · Reports · R46189 · HTML available · PDF available
Human Fetal Tissue Research: Frequently Asked Questions
2019-08-08 · Reports · R44129 · HTML available · PDF available
The Pharmaceutical Drug Development Process
2019-05-29 · Infographics · IG10013 · HTML available
Science and Technology Issues in the 116th Congress
2019-02-06 · Reports · R45491 · HTML available
The SUPPORT for Patients and Communities Act (P.L. 115-271): Food and Drug Administration and Controlled Substance Provisions
2018-11-15 · Reports · R45405 · HTML available · PDF available
Proposed Reorganization of U.S. Federal Food Safety Agencies
2018-09-07 · Resources · IF10974 · HTML available